136 related articles for article (PubMed ID: 38151791)
1. Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma.
Mackay S; Oduor IO; Burch TC; Troyer DA; Semmes OJ; Nyalwidhe JO
Prostate; 2024 Apr; 84(5):479-490. PubMed ID: 38151791
[TBL] [Abstract][Full Text] [Related]
2. Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue.
Yuan W; Liu B; Sanda M; Wei R; Benicky J; Novakova Z; Barinka C; Goldman R
Prostate; 2022 Jan; 82(1):132-144. PubMed ID: 34662441
[TBL] [Abstract][Full Text] [Related]
3. Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing.
Castelletti D; Fracasso G; Alfalah M; Cingarlini S; Colombatti M; Naim HY
J Biol Chem; 2006 Feb; 281(6):3505-12. PubMed ID: 16221666
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the main PSA glycoforms in aggressive prostate cancer.
Gratacós-Mulleras A; Duran A; Asadi Shehni A; Ferrer-Batallé M; Ramírez M; Comet J; de Llorens R; Saldova R; Llop E; Peracaula R
Sci Rep; 2020 Nov; 10(1):18974. PubMed ID: 33149259
[TBL] [Abstract][Full Text] [Related]
6. Decreased prostate-specific membrane antigen levels in the seminal plasma of oligoasthenoteratozoospermic men.
Arslan MA; Avcı B; Tunçel ÖK; Asci R
Andrologia; 2021 Feb; 53(1):e13840. PubMed ID: 33108820
[TBL] [Abstract][Full Text] [Related]
7. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
[TBL] [Abstract][Full Text] [Related]
8. An Insight into Glyco-Microheterogeneity of Plasma von Willebrand Factor by Mass Spectrometry.
Gashash EA; Aloor A; Li D; Zhu H; Xu XQ; Xiao C; Zhang J; Parameswaran A; Song J; Ma C; Xiao W; Wang PG
J Proteome Res; 2017 Sep; 16(9):3348-3362. PubMed ID: 28696719
[TBL] [Abstract][Full Text] [Related]
9. Increased α2,3-sialyl N-glycosylated prostate-specific membrane antigen (PSMA) in post-DRE urine is associated with high grade group prostate cancer.
Mackay S; Oduor IO; Burch TC; Main BP; Troyer DA; Semmes OJ; Nyalwidhe JO
Prostate; 2024 May; ():. PubMed ID: 38734979
[TBL] [Abstract][Full Text] [Related]
10. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.
White KY; Rodemich L; Nyalwidhe JO; Comunale MA; Clements MA; Lance RS; Schellhammer PF; Mehta AS; Semmes OJ; Drake RR
J Proteome Res; 2009 Feb; 8(2):620-30. PubMed ID: 19128049
[TBL] [Abstract][Full Text] [Related]
11. High-throughput glycopeptide profiling of prostate-specific antigen from seminal plasma by MALDI-MS.
Wang W; Kałuża A; Nouta J; Nicolardi S; Ferens-Sieczkowska M; Wuhrer M; Lageveen-Kammeijer GSM; de Haan N
Talanta; 2021 Jan; 222():121495. PubMed ID: 33167210
[TBL] [Abstract][Full Text] [Related]
12. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.
Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G
Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837
[TBL] [Abstract][Full Text] [Related]
13. Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients.
Holmes EH; Greene TG; Tino WT; Boynton AL; Aldape HC; Misrock SL; Murphy GP
Prostate Suppl; 1996; 7():25-9. PubMed ID: 8950359
[TBL] [Abstract][Full Text] [Related]
14. Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin.
Arnold JN; Wormald MR; Suter DM; Radcliffe CM; Harvey DJ; Dwek RA; Rudd PM; Sim RB
J Biol Chem; 2005 Aug; 280(32):29080-7. PubMed ID: 15955802
[TBL] [Abstract][Full Text] [Related]
15. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
Tajiri M; Ohyama C; Wada Y
Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937
[TBL] [Abstract][Full Text] [Related]
16. Micro- and macroheterogeneity of N-glycosylation yields size and charge isoforms of human sex hormone binding globulin circulating in serum.
Sumer-Bayraktar Z; Nguyen-Khuong T; Jayo R; Chen DD; Ali S; Packer NH; Thaysen-Andersen M
Proteomics; 2012 Nov; 12(22):3315-27. PubMed ID: 23001782
[TBL] [Abstract][Full Text] [Related]
17. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy.
Christiansen JJ; Rajasekaran SA; Inge L; Cheng L; Anilkumar G; Bander NH; Rajasekaran AK
Mol Cancer Ther; 2005 May; 4(5):704-14. PubMed ID: 15897234
[TBL] [Abstract][Full Text] [Related]
18. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract][Full Text] [Related]
19. A dual-monoclonal sandwich assay for prostate-specific membrane antigen: levels in tissues, seminal fluid and urine.
Sokoloff RL; Norton KC; Gasior CL; Marker KM; Grauer LS
Prostate; 2000 May; 43(2):150-7. PubMed ID: 10754531
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
Hofman MS; Murphy DG; Williams SG; Nzenza T; Herschtal A; Lourenco RA; Bailey DL; Budd R; Hicks RJ; Francis RJ; Lawrentschuk N
BJU Int; 2018 Nov; 122(5):783-793. PubMed ID: 29726071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
